␤1-and ␤2-adrenergic receptors (AR) regulate cardiac myocyte function through distinct signaling pathways. In addition to regulating cardiac rate and contractility, ␤1AR and ␤2AR may play different roles in the pathogenesis of heart failure. Studies on neonatal cardiac myocytes from ␤1AR and ␤2AR knockout mice suggest that subtype-specific signaling is determined by subtypespecific membrane targeting and trafficking. Stimulation of ␤ 2 ARs has a biphasic effect on contraction rate, with an initial increase followed by a sustained G i-dependent decrease. Recent studies show that a PDZ domain-binding motif at the carboxyl terminus of human ␤2AR interacts with ezrin-binding protein 50͞sodium-hydrogen exchanger regulatory factor, a PDZ-domain-containing protein. The human ␤2AR carboxyl terminus also binds to Nethylmaleimide-sensitive factor, which does not contain a PDZ domain. We found that mutation of the three carboxyl-terminal amino acids in the mouse ␤2AR (␤2AR-AAA) disrupts recycling of the receptor after agonist-induced internalization in cardiac myocytes. Nevertheless, stimulation of the ␤2AR-AAA produced a greater contraction rate increase than that of the wild-type ␤2AR. This enhanced stimulation of contraction rate can be attributed in part to the failure of the ␤2AR-AAA to couple to Gi. We also observed that coupling of endogenous, wild-type ␤2AR to Gi in ␤1AR knockout myocytes is inhibited by treatment with a membrane-permeable peptide representing the ␤2AR carboxyl terminus. These studies demonstrate that association of the carboxyl terminus of the ␤2AR with ezrin-binding protein 50͞sodium-hydrogen exchanger regulatory factor, N-ethylmaleimide-sensitive factor, or some related proteins dictates physiologic signaling specificity and trafficking in cardiac myocytes. T he ␤-adrenergic receptors (ARs) are essential for the physiologic regulation of cardiac function by the sympathetic nervous system (1), and may play important roles in the pathogenesis of heart failure (2). The three known subtypes of ␤ARs (␤ 1 AR, ␤ 2 AR, and ␤ 3 AR) belong to the large family of G protein-coupled receptors. Although all three subtypes have been detected in mammalian hearts (3), most of the functional responses to ␤-agonists can be attributed to ␤ 1 AR and ␤ 2 AR (3, 4). Although ␤ 1 AR and ␤ 2 AR respond to the same physiologic ligands (the hormone epinephrine and the neurotransmitter norepinephrine), they have distinct functional properties in vivo (5, 6). Specifically, ␤ 1 AR knockout mice lack the normal inotropic and chronotropic response to the adrenergic agonist isoproterenol (6), whereas these responses are preserved in ␤ 2 AR knockout mice (5).
T
he ␤-adrenergic receptors (ARs) are essential for the physiologic regulation of cardiac function by the sympathetic nervous system (1) , and may play important roles in the pathogenesis of heart failure (2) . The three known subtypes of ␤ARs (␤ 1 AR, ␤ 2 AR, and ␤ 3 AR) belong to the large family of G protein-coupled receptors. Although all three subtypes have been detected in mammalian hearts (3) , most of the functional responses to ␤-agonists can be attributed to ␤ 1 AR and ␤ 2 AR (3, 4) . Although ␤ 1 AR and ␤ 2 AR respond to the same physiologic ligands (the hormone epinephrine and the neurotransmitter norepinephrine), they have distinct functional properties in vivo (5, 6) . Specifically, ␤ 1 AR knockout mice lack the normal inotropic and chronotropic response to the adrenergic agonist isoproterenol (6) , whereas these responses are preserved in ␤ 2 AR knockout mice (5) .
When expressed in undifferentiated fibroblast cells, ␤ 1 AR and ␤ 2 AR exhibit similar signaling properties (7) . However, recent studies suggest that these subtypes activate different signaling pathways in differentiated cells in vivo (8, 9) . We have recently reported that ␤ 1 AR and ␤ 2 AR regulate the intrinsic contraction rate in mouse neonatal myocytes through different signaltransduction pathways (4) . Activation of ␤ 1 ARs leads to a PKA-dependent increase in contraction rate. In contrast, activated ␤ 2 ARs undergo sequential coupling to G s and G i , which has a biphasic effect on contraction rate, with an initial PKAindependent increase followed by a sustained decrease that can be blocked by pertussis toxin (PTX) (4) . The functional differences between ␤ 1 AR and ␤ 2 AR in cardiac myocytes are mediated in part by subtype-specific targeting of the receptors on the myocyte plasma membrane (10, 11) . Immunofluorescence and membrane fractionation studies show that the ␤ 2 ARs are concentrated in caveolar structures, whereas the ␤ 1 ARs are mainly distributed in noncaveolar membrane in cardiac myocytes (11, 12) . Disruption of caveolar structures in cardiac myocytes selectively enhances and prolongs the increase in myocyte contraction rate mediated by ␤ 2 AR activation, but has no effect on signaling by the ␤ 1 AR (12) . Moreover, studies show that ␤ 2 AR signaling can modulate L-type Ca 2ϩ channel activity in distinct subcellular microdomains in hippocampal neurons and cardiac myocytes (13) (14) (15) . These observations suggest that subtypespecific signaling complexes conduct ␤ 1 AR and ␤ 2 AR signaling in cardiac myocytes.
A growing body of evidence from in vitro studies supports the notion that G protein-coupled receptors can form complexes with downstream effectors to facilitate signaling. Activated ␤ 2 AR recruits ␤-arrestin that scaffolds many trafficking molecules such as clathrin, AP-2, and ARF, and signaling molecules including the tyrosine kinase Src and mitogen-activated kinases c-Jun amino-terminal kinase and extracellular signal-regulate kinase 1͞2 (16) . ␤ 2 ARs can also associate with AKAP79 and Gravin, which are scaffolding proteins that connect ␤ 2 AR to PKA, PKC, PP2A, and L-type Ca ϩ channels (17) (18) (19) . Moreover, interactions mediated by carboxyl-terminal PDZ-domainbinding motifs serve as another general mechanism to recruit G protein-coupled receptors into signaling complexes. Studies show that the ␤ 1 AR PDZ motif can interact with postsynaptic scaffolding proteins PSD-95 (synaptic associated protein 90) and membrane-associated guanylate-inverted 2 in HEK293 cells (20, 21) . In cardiac myocytes, the interaction between ␤ 1 AR PDZ motif with PSD-95 or related proteins dictates signaling specificity by retaining the receptor at the cell surface and preventing interaction with G i proteins (22) .
It has been shown that the ␤ 2 AR carboxyl-terminal PDZ motif interacts with the Na ϩ ͞H ϩ exchanger regulatory factor [NHERF, also known as ezrin-binding protein 50 (EBP50) (23, 24) ], which affects Na ϩ ͞H ϩ exchange in HEK293 cells (23) . The ␤ 2 AR carboxyl terminus also binds to N-ethylmaleimidesensitive factor (NSF) (25) , which does not contain a PDZ domain. This interaction is critical for receptor recycling to the plasma membrane after agonist-induced internalization. However, the functional role of an interaction between the ␤ 2 AR carboxyl terminus and its associated protein(s) in cardiac myocytes has not been reported. To examine the role of the ␤ 2 AR carboxyl terminus on receptor trafficking and signaling in neonatal cardiac myocytes, we generated recombinant adenovirus expressing a mutant ␤ 2 AR in which the three carboxyl-terminal amino acids are mutated to alanine (␤ 2 AR-AAA). This mutation is predicted to disrupt interactions with NSF-and PDZ-domain-containing proteins. We compared the functional properties of wild-type ␤ 2 AR and ␤ 2 AR-AAA in neonatal myocytes from ␤ 1 ͞␤ 2 AR knockout (KO) mice. Our results demonstrate that the carboxyl terminus of the ␤ 2 AR is essential for physiologic signaling and trafficking in cardiac myocytes.
Materials and Methods

Culture and Adenovirus Infection of Neonatal Mouse Ventricular
Myocytes. Spontaneously beating neonatal cardiac myocytes were prepared from hearts of 1-day-old mouse pups (from wild-type, ␤ 1 AR-KO, ␤ 2 AR-KO, and ␤ 1 ͞␤ 2 AR-KO mice) as described (4) . The myocyte-enriched cells remaining in suspension after preplating were plated in 35-mm dishes for contraction-rate studies, in 12-well plates for ELISA, in 12-well plates with coverslips for immunocytochemistry, or in 10-cm dishes for Western blot and ligand-binding assays as described (22) .
Recombinant adenovirus encoding amino-terminal Flagtagged mouse ␤ 2 AR-AAA (the ␤ 2 AR carboxyl terminus DSPL was mutated into DAAA) was generated with the pAdEasy system (Q.biogen, Carlsbad, CA); adenoviruses encoding HA-␤ 1 AR-PDZmut and Flag-␤ 2 AR were described (12, 22) . Neonatal myocytes were infected with viruses at a multiplicity of infection of 100 after being cultured for 24 h as described (12) .
Measurement of Myocyte Contraction Rate and cAMP Accumulation.
Measurement of spontaneous contraction rate was carried out as described (4) . In the time-course experiments, statistical significance between groups was analyzed with two-way analysis of variance with PRISM software (GraphPad, San Diego). Myocyte cAMP accumulation was determined by using a RIA as described (12) .
Tat peptide, Tat-␤ 2 -DSPL consisting of Tat linked to GRQG-FSSDSPL of ␤ 2 AR, Tat-␤ 2 -DAAA consisting of Tat linked to GRQGFSSDAAA, Tat-␤ 2 -DSAL consisting of Tat linked to GRQGFSSDSAL, and Tat-␤ 2 -ASPL consisting of Tat linked to GRQGFSSASPL through a cysteine bridge were synthesized in the Stanford Core facility. Neonatal myocytes were preincubated at 37°C with 1 M peptide (Tat, Tat-␤ 2 -DSPL, Tat-␤ 2 -DAAA, Tat-␤ 2 -DSAL, or Tat-␤ 2 -ASPL) for 25 min, or filipin (2 g͞ml; Sigma) for 30 min before isoproterenol (10 M; Sigma) exposure. In some assays, PTX (0.75 g͞ml; Sigma) or PKI (20 M; Calbiochem) was used as described (12) before isoproterenol stimulation.
Immunofluoresence Microscopy and ELISA. Myocytes cultured on coverslips were infected with the Flag-␤ 2 AR, Flag-␤ 2 AR-AAA, or HA-␤ 1 AR-PDZmut adenoviruses as described above. Myocytes were pulsed with 10 M isoproterenol for 10 min. The cells were either fixed with 1ϫ PBS containing 5% paraformaldhyde or washed three times before being chased for 15, 30, or 60 min with medium containing 1 M aprenelol. The fixed cells were permeablized with 1ϫ PBS containing 1% Nonidet P-40, and stained with anti-Flag M1 antibody (mouse monoclonal IgG 2b , 1:600 dilution; Sigma) or anti-HA 16B12 antibody (mouse monoclonal IgG 1 , 1:600 dilution; Covance, Berkeley, CA). The primary antibodies were detected with FITC-conjugated goat anti-mouse IgG 2b (1:200) and Texas red-conjugated goat anti-mouse IgG 1 (1:400; Fisher). The images were acquired with a Zeiss Axioplan 2 microscope. Quantitative analysis of myocyte cell-surface receptors was carried out with ELISA as described (22) .
Ligand Binding and Western Blot Analysis. Membrane proteins were prepared from adenovirus-infected ␤ 1 ͞␤ 2 AR-KO myocytes as described (22) . Saturation binding was carried out with 20 nM nonselective ␤AR antagonist [ ]dihydroalprenolol, and different concentrations of the ␤ 2 AR antagonist ICI118551 or the ␤AR agonist isoproterenol. Membrane proteins were subjected to Western blot analysis with anti-Flag M1 antibody as described (22) .
Results
Mutation of the Carboxyl-Terminal Three Amino Acids of the ␤2AR
Inhibits Receptor Coupling to G i. To study the role of the ␤ 2 AR PDZ motif in receptor function in neonatal cardiac myocytes, we generated a recombinant adenovirus expressing a mutant ␤ 2 AR that lacks a functional PDZ motif (Flag-␤ 2 AR-AAA). This mutation would also be predicted to disrupt interactions between the ␤ 2 AR and NSF (25) . Flag-␤ 2 AR and Flag-␤ 2 AR-AAA were expressed in ␤ 1 ͞␤ 2 AR-KO neonatal myocytes by recombinant adenovirus infection at a multiplicity of infection of 100. Both receptors could be efficiently expressed in neonatal myocytes, and the levels of the functional receptor expression were similar (Fig. 1A) . Moreover, ␤ 2 AR-AAA and the wild-type ␤ 2 AR displayed similar binding affinities to the agonist isoproterenol and to the ␤ 2 AR-selective antagonist ICI118551 (Fig. 1B) . Fig. 2 shows the effect of isoproterenol on the contraction rate of ␤ 1 AR-KO myocytes or ␤ 1 ͞␤ 2 AR-KO myocytes expressing either Flag-␤ 2 AR or Flag-␤ 2 AR-AAA. The activated Flag-␤ 2 ARs induce a contraction rate response in the ␤ 1 ͞ ␤ 2 AR-KO myocytes similar to that induced by the activated endogenous ␤ 2 AR in the ␤ 1 AR-KO myocytes. The response displayed an initial increase followed by a decrease to below the basal level (Fig. 2 A) (4) . In comparison with the wild-type ␤ 2 AR, the activated ␤ 2 AR-AAA induced a much more robust contraction-rate increase, and the contraction rate did not drop below the basal level (Fig. 2B) . We have previously shown that ␤ 2 ARs are enriched in the caveolar structures on myocyte plasma membrane. Filipin, a reagent that disrupts caveolar structure by binding cholesterol, selectively enhances and prolongs the contraction-rate increase mediated by ␤ 2 ARs, but not by ␤ 1 ARs (4). Disruption of caveolar structures with filipin also enhanced the contraction rate increase induced by the activated ␤ 2 AR-AAA (Fig. 2C) . We also examined cAMP accumulation in the cultures of ␤ 1 ͞␤ 2 AR-KO myocytes expressing either the Flag-␤ 2 AR or the Flag-␤ 2 AR-AAA. In contrast to the different contraction-rate responses, the cAMP accumulations by the activated receptors were not significantly different in the myocytes expressing either ␤ 2 ARs (basal, 10.6 Ϯ 2.9 pmol per dish; isoproterenol, 35.6 Ϯ 5.5 pmol per dish) or ␤ 2 AR-AAA (basal, 10 Ϯ 3.8 pmol per dish; isoproterenol, 37.7 Ϯ 5.8 pmol per dish).
The biphasic contraction-rate response mediated by the activated ␤ 2 AR is due to sequential coupling of the receptor to G s and G i (4). PTX, a G i protein inhibitor, efficiently prevents the secondary decrease in contraction rate induced by activation of the ␤ 2 AR (Fig. 3A) . The larger, monophasic contraction-rate response to stimulation of the ␤ 2 AR-AAA suggests a limited role of G i signaling. Furthermore, pretreatment of myocytes with PTX had no significant effect on the contraction rate induced by the ␤ 2 AR-AAA (Fig. 3B) . Thus, the ␤ 2 AR-AAA appears to couple only to G s in ␤ 1 ͞␤ 2 AR-KO neonatal myocytes. We also examined the role of PKA in the contraction-rate response induced by the wild-type ␤ 2 AR and the ␤ 2 AR-AAA. We have previously shown that PKI, a selective PKA inhibitor, has no significant effect on the ␤ 2 AR-mediated contraction-rate increase at concentrations that markedly inhibit ␤ 1 AR signaling (4). Thus, the ␤ 2 AR normally stimulates contraction rate through a PKAinsensitive mechanism, possibly through activation of the cAMP-gated, nonselective cation channel. PKI partially inhibits the maximum contraction-rate increase after ␤ 2 AR-AAA stimulation (Fig. 3C) . 
Mutation of the Carboxyl-Terminal Three Amino Acids of the ␤2AR Disrupts Receptor Recycling After Endocytosis in Neonatal Myocytes.
Immunostaining shows that both Flag-␤ 2 AR and Flag-␤ 2 AR-AAA are localized predominantly on the cell surface of neonatal myocytes at steady state (Fig. 4A) . On isoproterenol stimulation, both receptors undergo significant internalization, as indicated by punctate intracellular staining (Fig. 4 A) . Quantitative ELISAs confirm that isoproterenol stimulation causes an equivalent (Ϸ21-24%) decrease in cell-surface receptor density in the myocytes expressing either the Flag-␤ 2 AR or the Flag-␤ 2 AR-AAA (Fig. 4C) . However, whereas the wild-type ␤ 2 AR efficiently recycles back to the cell surface, the mutant Flag-␤ 2 AR-AAA fails to do so (Fig. 4 B and C) . These results are consistent with previously published studies (24) and suggest that the ␤ 2 AR PDZ motif is required for the receptor recycling to the cell surface and for the receptor coupling to G i in the myocytes. In contrast, mutation of the PDZ-binding motif in the ␤ 1 AR has very different consequences. Disruption of the PDZ motif in the HA-␤ 1 AR (HA-␤ 1 AR-PDZmut) dramatically enhances agonist-induced internalization and promotes coupling to G i in the neonatal myocytes. In contrast to the ␤ 2 AR-AAA, the ␤ 1 AR-PDZmut efficiently recycles back to the cell surface after isoproterenol-induced internalization in myocytes (Fig. 4 B  and C) .
A Membrane-Permeable Peptide Containing the ␤2AR Carboxyl Terminus Alters ␤2AR Signaling in Cardiac Myocytes. The experiments using adenovirus to express ␤ 2 AR-AAA in ␤ 1 ͞␤ 2 AR-KO myocytes provide strong evidence for a functionally important interaction between the ␤ 2 AR and a PDZ-domain-containing protein, such as EBP50͞NHERF, or another protein that binds to the ␤ 2 AR carboxyl terminus, such as NSF. To confirm these observations with endogenously expressed ␤ 2 AR, we used a membrane-permeable peptide representing the wild-type ␤ 2 AR carboxyl terminus (Tat-␤ 2 -DSPL) to interfere with the interaction between the endogenous ␤ 2 ARs and their binding partners in ␤ 1 AR-KO myocytes. In comparison with the control cells, the Tat-␤ 2 -DSPL-treated myocytes showed a greater maximum contraction-rate increase, and the contraction rate did not decrease below the basal level (Fig. 5A) . In contrast, the control peptide, Tat-Flag-␤ 2 -DAAA, had no significant affect on the contraction rate (Fig. 5B) . Previous studies have shown that disruption of the carboxyl-terminal PDZ motif of the human ␤ 2 AR could alter binding to NHERF͞EBP50, a PDZ-domaincontaining protein, and NSF, a protein that lacks a PDZ domain (25) . Interactions between these proteins could be distinguished by more selective mutations of the carboxyl terminus (25) . We therefore examined the effect of two additional Tat-peptides, Tat-␤ 2 -ASPL and Tat-␤ 2 -DSAL. Based on the D410A mutation in the human ␤ 2 AR (25), Tat-␤ 2 -ASPL would not be expected to bind NHERF͞EBP50. We found that, like Tat-␤ 2 -DAAA, Tat-␤ 2 -ASPL had no effect on myocyte contraction rates (Fig. 5C) . Based on the L412A mutation in the human ␤ 2 AR (25), Tat-␤ 2 -DSAL would be expected to bind NHERF͞EBP50, but not NSF. The carboxyl terminus of the mouse ␤ 2 AR (-DSPL) differs from the human (-DSLL), and it is not known whether the wild-type mouse ␤ 2 AR binds to NSF. Myocytes treated with Tat-␤ 2 -DSAL exhibited the same behavior as myocytes treated with Tat-␤ 2 -DSPL, showing a greater agonist-stimulated contraction rate (Fig. 5D) . Thus, our results suggest that peptides that can bind NHERF͞EBP50 can selectively modulate ␤ 2 ARmediated signaling in cardiac myocytes by competing with the endogenous ␤ 2 ARs for binding to one or more PDZ-domaincontaining proteins. Discussion ␤-Adrenergic receptors play critical roles in mediating physiologic responses to the hormone epinephrine and the neurotransmitter norepinephrine in animal hearts. Both ␤ 1 AR and ␤ 2 AR are expressed in cardiac myocytes and respond to the same stimuli, but they possess distinct functions in vivo. We have previously shown that ␤ 1 AR and ␤ 2 AR display different trafficking and signaling properties in neonatal myocytes. Activated ␤ 1 ARs remain on the cell surface and couple to G s (22) . In contrast, activated ␤ 2 ARs undergo robust endocytosis, and the receptors couple sequentially to G s and G i in cardiac myocytes (4) . A mutation disrupting the interaction between the ␤ 1 AR PDZ motif and its binding partners enables agonist-induced receptor internalization (22) . The same mutation also enables the receptor to couple sequentially to G s and G i after activation (22) .
In this study, we examined the effect of mutating the carboxylterminal amino acids of the mouse ␤ 2 AR. Based on previous studies (25), ␤ 2 AR-AAA should not bind to NSF or PDZ domain proteins such as NHERF͞EBP50. Stimulation of wildtype ␤ 2 AR induces a biphasic contraction-rate response in neonatal myocytes, with an initial G s -dependent increase in contraction rate and a secondary G i -dependent decrease in contraction rate below baseline. In contrast, stimulation of ␤ 2 AR-AAA leads to a larger, more sustained increase in contraction rate that does not decrease below baseline and is not altered by pretreatment of cells with PTX. These results are most consistent with the failure of ␤ 2 AR-AAA to couple to G i . One must also consider the possibility that G i coupling is masked by much more efficient coupling of ␤ 2 AR-AAA to G s , thereby exceeding the cAMP levels needed for maximum contractionrate response. However, we found that it is possible to further stimulate contraction rate with forskolin after isoproterenol stimulation of ␤ 2 AR-AAA (data not shown). Thus, we feel our results are most consistent with a failure of ␤ 2 AR-AAA to couple to G i . Moreover, the results of the Tat-peptide studies (Fig. 5) suggest that the failure of ␤ 2 AR-AAA to couple to G i is caused by disruption of an interaction with a PDZ-domaincontaining protein, such as NHERF͞EBP50, and not by disruption of an interaction with NSF.
It has recently been reported that activation of G s by ␤ARs is involved in inducing myocyte apoptosis, whereas activation of G i confers a protective effect against myocyte apoptosis (26, 27) . The dual signaling mediated by ␤ 2 ARs in cardiac myocytes may represent a sophisticated mechanism enabling enhanced cardiac function in response to acute increases in sympathetic tone, but protecting myocytes from the detrimental effects of chronic catecholamine stimulation. Indeed, moderate overexpression of ␤ 2 AR in the heart of transgenic mice leads to an enhanced cardiac contractility without developing cardiomyopathy (28) . In contrast, overexpression of the ␤ 1 AR leads to heart failure (29) . Because the coupling of ␤ 2 ARs to G i is inhibited by mutation of the PDZ binding motif, we might expect that a similar mutant expressed in vivo would have a significant and possibly detrimental effect in animal hearts under chronic stress.
Filipin is a reagent that disrupts caveolar structures in cardiac myocytes. Filipin does not affect the basal contraction rate and has no effect on ␤ 1 AR stimulation of contraction rate; however, it selectively enhances the contraction-rate increase after stimulation of ␤ 2 AR (12) . In this study, the ␤ 2 AR-AAA-induced contraction-rate increase under isoproterenol stimulation is further enhanced by filipin. Thus, the PDZ motif may not be required for the targeting of the ␤ 2 AR to caveolae in cardiac myocytes. In contrast to the wild-type ␤ 2 AR, the contractionrate increase induced by ␤ 2 AR-AAA is partially inhibited by the PKA inhibitor PKI (Fig. 3C) . This inhibition suggests that the enhanced coupling of the ␤ 2 AR-AAA to an increase in contraction rate is due in part to activation of a PKA-dependent pathway that is not activated by the wild-type ␤ 2 AR. This altered signaling may be explained by the inability of the ␤ 2 AR-AAA to associate with regulatory components of a signaling complex. ␤ 2 ARs associate with different scaffold proteins, including arrestin, A-kinase associate protein (AKAP), NSF, and the PDZ- domain-containing protein NHERF͞EBP50 (16) . EBP50 associates with an A-kinase-anchoring protein (AKAP) ezrin (23) . A muscle-specific mAKAP can scaffold both PKA and a phosphodiesterase PDE4D in cardiac myocytes (30) . Therefore, the signaling complexes containing the ␤ 2 ARs can orchestrate tight regulation of the second messenger cAMP within a plasma membrane microdomain (31) . For example, disruption of the PDZ-mediated interaction between ␤ 2 ARs and PDE4 may allow cAMP to diffuse over a larger subcellular volume, thereby activating signaling pathways not normally activated by the wild-type ␤ 2 AR. We did not observe detectable differences in the whole-cell cAMP accumulation stimulated by the wild-type ␤ 2 AR and ␤ 2 AR-AAA. However, the cAMP studies were performed in myocytes that are preincubated with a phosphodiesterase inhibitor (3-isobutyl-1-methylxanthine) .
In contrast to the inhibitory effect of mutating the ␤ 2 AR PDZ-binding motif on receptor coupling to G i , mutation of the PDZ-binding motif in the ␤ 1 AR promotes coupling to G i in the neonatal myocytes (12) . The ability of these receptors to couple to G i correlates with their propensity to undergo agonist-induced internalization and recycle back to the plasma membrane. The wild-type ␤ 1 AR does not undergo agonist-induced internalization, and the ␤ 2 AR-AAA cannot recycle back to the cell surface after internalization. In contrast, both the wild-type ␤ 2 AR and ␤ 1 AR-PDZmut undergo agonist-induced internalization and efficient recycling to the plasma membrane (Fig. 4C) . The role of the PDZ-binding motif in subtype-specific trafficking has previously been demonstrated in HEK293 cells. The ␤ 1 AR PDZ motif has been shown to interact with two postsynaptic scaffold proteins, PSD-95 (synaptic associated protein 90) (20) and membrane-associated guanylate-inverted 2 (21), in HEK293 cells. In contrast, the ␤ 2 AR PDZ motif selectively associates with EBP50͞NHERF (23, 24) and NSF (25) . Although overexpression of PSD-95 in HEK293 cells inhibits agonist-induced internalization of the ␤ 1 AR (20) , mutations disrupting of the interaction between the human ␤ 2 AR and NSF inhibit receptor recycling (25) . However, it is noteworthy that a key residue (leucine 410) in human ␤ 2 AR necessary for NSF binding is not conserved in the mouse ␤ 2 AR used in this study. Therefore, we cannot be certain that disruption of interactions between NSF and the mouse ␤ 2 AR account for the failure of ␤ 2 AR-AAA to efficiently recycle after agonist-induced internalization (Fig. 4) .
In conclusion, we present evidence that the ␤ 2 AR PDZ motif is essential for the physiologic signaling of this receptor subtype in neonatal mouse cardiac myocytes. Disruption of the ␤ 2 AR PDZ motif inhibited receptor recycling after isoproterenolinduced internalization and inhibited the receptor coupling to G i . These results, together with our previous studies on the ␤ 1 AR, demonstrate that interactions between ␤-adrenergic receptors and specific PDZ-domain-containing proteins play an essential role in subtype-specific signaling of ␤-adrenergic receptors in cardiac myocytes. These interactions may serve to organize receptors, G proteins, effectors, and regulatory proteins into discrete signaling complexes in the plasma membrane (13) . The formation of signaling complexes facilitates local, rapid, and highly specific cellular responses in vivo.
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